Half year of 2022 passed, we faced a lot of challenges, but we did some achievements, mid-year sales review meeting was held on July 20.
Thanks for all customers’ support, sales revenue increased 169% in the first half of 2022 compared to the first half of 2021, PTCA balloon catheter and NC PTCA balloon catheter contributes 74% of the amount. Sirolimus-eluting stent system has the highest increasing rate, more and more clients ordered them and gave good feedback.
We set new targets for the second half year of 2022 and try our best to serve our clients better with a grateful heart.
#Balloon #PTCAballoon #Catheter #KosselMedical